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The biological diversity of the immune system is reflected in the variety of immune 
effector systems  and  mediation  pathways  that  have  emerged.  Among  the  least 
recognized involve the hemostatic pathways. The possibility of cellular and molecular 
linkages between two host defense mechanisms, the hemostatic and immune systems, 
has long been suggested, but has yet to be satisfactorily delineated. To support the 
probability  of such  linkages,  intradermal  deposition  of fibrin  is  recognized  as  a 
prominent and consistent feature of the delayed-cutaneous-hypersensitivity reaction 
(DCH) 1 (1,  2).  Indeed,  recent  studies  have  demonstrated  that  fibrin  deposition  is 
required for the phenotypic expression of DCH, i.e., induration (3). That the macro- 
phage is also critically important  to this phenomenon is suggested by observations 
that carageenan abrogates the development of this tissue lesion (4). Other provocative 
observations linking the hemostatic system to immune responses include the deposition 
of fibrin  in  the  lesions  of allogeneic  rejection  (5),  the  massive  accumulation  of 
intraglomerular fibrin in experimental anti-glomerular-basement-membrane-type glo- 
merulonephritis when animals are given the fibrinolytic inhibitor ~-aminocaproic acid 
(6),  the  appearance  of perivascular  fibrinogen  or  fibrin  as  the  earliest  feature  of 
experimental  allergic encephalomyelitis  (7),  and  the  characteristics  of the  general 
Schwartzman phenomenon (8). 
These observations have been complemented by in vitro studies demonstrating that 
the significant but relatively modest content of procoagulant activity (PCA) of human 
peripheral  blood mononuclear cells  is  markedly increased  by exposure to  antigen- 
antibody complexes (9), allogeneic cells in mixed lymphocyte cultures (10), culture in 
the presence of mitogenic lectins  (11), bacterial lipopolysaccharides (LPS)  (12,  13) 
and by proteolytic products of C5 (14). The PCA of mononuclear lymphoid cells has 
been attributed to tissue factor, a  cellular membrane lipoprotein that  binds Factor 
VII, induces specific enzymatic activity, and, via Factor X  and prothrombin in the 
presence of Factor V, culminates in the conversion of fibrinogen to fibrin (15,  16). 
The cellular events involved in the induction of PCA activity has received limited 
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attention.  Indeed,  though  it  has  been  suggested  that  the  monocyte/macrophage 
possesses PCA activity (16), cellular localization and the requirements for collaborative 
cellular interactions have not been firmly established. In our study, we provide direct 
evidence that  a  small proportion of murine splenic macrophages possess basal PCA 
activity, and that  after exposure to LPS, it is the macrophage that  accounts for the 
profound  increase  in  PCA.  However,  the  amplification of  both  viable  and  total 
content  maerophage  PCA  by  LPS  requires  cellular collaboration  that  appears  to 
involve a  direct cellular interaction of macrophages with lymphocytes that have been 
first exposed to LPS, a  previously undescribed scheme of cellular collaboration. 
Materials  and  Methods 
Spleen  Cells.  Spleens were removed asceptically from 6- to 8-wk-old male strain A/St or 
BALB/c mice (L. C. Strong Laboratory, San Diego, Calif.) and cells were suspended in Hepes- 
buffered minimal essential medium (HMEM) that consisted of bicarbonate-free Eagle's mini- 
mum essential medium (Flow Laboratories, Rockville, Md.) that contained 25 mM Hepes, 2.5 
mM  NaOH,  100  U  penicillin/ml, and  50  ~g  streptomycin/ml  (Gibeo  Diagnostics, Gibco 
Invenex Div., Chagrin Falls, Ohio) at pH 7.3. Mononuclear cells were isolated by centrifugation 
over Fieoll-Hypaque at  22°C  for  12  min  at  1,400 g  at the interface  (17).  Mononuclear cells 
from the interface were >98% lymphocytes or monocyte/macrophages by cytologic examination 
of giemsa stained smears. Cells were washed twice with HMEM before use. 
Adherent cells (maerophages) were isolated by incubation of mononuclear cells in complete 
medium at 5 ×  10  n cells/ml for 45 min at 1 ml in 16-mm-diameter plastic tissue culture 24-well 
plates (Costar, Data Packaging, Cambridge, Mass.) at 37°C and 5% CO2  (18).  Nonadherent 
cells (lymphocytes) were decanted, subjected to an  additional cycle of adherence,  decanted 
again, and assayed for viability (>98% by trypan blue) and freedom from macrophages (<1% 
by neutral-red uptake and by esterase staining). Recovery of lymphocytes was 86 +  3%. The 
macrophage monolayer was washed twice with HMEM and the identity of adherent cells as 
viable macrophages was confirmed by vital uptake of neutral red and a  positive reaction for 
esterase with >99% of cells positive by both criteria. Macrophages were detached by agitation 
at  150 rpm on a  gyrotory platform (Model G2;  New Brunswick Scientific Co., Inc., Edison, 
N. J.)  for 25 min at 22°C in the presence of 3% bovine serum albumin (Calbiochem-Behring 
Corp., American Hoechst Corp., San Diego, Calif.), Hepes-buffered Puck's saline A  (0.4 gm% 
KCI, 8.0 gm% NaC1,  20 mM Hepes, pH 7.3,  1 gin% glucose, and 0.005%  phenol red)  (Gibco 
Diagnostics, Gibco Invenex Div.) that contained 3 mM EDTA (Sigma Chemical Co., St. Louis, 
Mo.). Recovery of maerophages was 78 +  2%. 
Culture.  Cells were cultured at  5  ×  106/ml  in  1-ml volumes in  16-mm  diameter, 24-well 
plates in complete medium consisting of 10% heat-inactivated fetal calf serum in 25 mM Hepes, 
0.2 gm% sodium bicarbonate, 2 mM glutamine, 100 U  penicillin/ml, and 50 #g streptomycin/ 
ml  (Gibco Diagnostics, Gibco Invenex Div.) in Eagle's minimum essential medium. Cultures 
were stimulated with  10/~g of LPS  (from Escherichia  coli 011 l:B4)  prepared by the butanol 
extraction method  (19)  and  provided by Dr.  David Morrison, Research Institute of Scripps 
Clinic, La Jolla, Calif. Cells were cultured at 37°C in a 5% CO2 atmosphere. 
PCA Assay.  Samples of viable cells or frozen-thawed and sonicated cells in HMEM were 
assayed for the capacity to shorten the spontaneous clotting time of human plasma in a one- 
stage clotting assay. Cells were sonicated in 0.5  ml of HMEM  in  12  ×  75-mm tubes with a 
microtip probe of a  Heat Systems-Ultrasonics, Inc. (Plainview, N. Y.)  model W-140 sonicator 
at a setting of 3 using two bursts of 10 sec each with ice-cooling. The vol was brought to 1.0 ml 
with HMEM, and PCA was determined from the clotting time at 37°C in recalcified, diluted 
normal plasma; for greater sensitivity and linearity at low PCA, severe Factor-VIII-deficient 
(hemophilia A) plasma was used. This corrected the recognized deviation and Factor VIII and 
IX dependence of low thromboplastin concentrations (20, 21). The assay consisted of 0.1 ml of 
test sample (or rabbit brain thromboplastin standard) plus 0.1  ml of citrated, normal fasting 
human plasma in 12- ×  75-mm tube to which was added 0.1 ml of 25 mm CaCI~ to initiate the 
assay. The rabbit brain thromboplastin standard at 36 mg (dry mass)/ml (Dade Div., American 1234  MACROPHAGE  PROCOAGULANT ACTIVITY 
Hospital Supply Corp., Miami, Fla.) was assigned a value of 100,000 milliunits. There was no 
activity present in HMEM, complete medium, or macrophage-detaching solution. The assay 
was used over the range of 1-10,000 milliunits,  or l0  s to 108 cells, which was linear when using 
severe Factor-VIII-deficient  plasma or 10  ~- 108 cells with normal plasma substrate. The precision 
(coefficient of variation) of assays was 8.7% at the lower limit and 7.0% at the upper limit. The 
molecular pathways will be described in detail in a subsequent study. 
PCA Plaque Assay.  For cellular localization of PCA to single viable cells, cell  suspensions 
were incubated on glass microscope slides at 37°C for 2 h in complete medium in 5% CO2. The 
medium was  removed without  displacing the  cells,  and  the  cells  were  overlaid with  1.5% 
agarose  (Indubiose A-37; L'Industrie Biologique, Francaise, S.A.)  dissolved  in a  mixture of 
three  volumes of HMEM  that  contained 3.67  gm%  CaCI  and one volume of platelet-free, 
citrate, normal human plasma. The plasma was added to the agarose at 38-39°C and 1.0-1.5 
ml was  immediately poured on the slide and allowed to spread while maintained at  37°C. 
After a  10-rain  incubation period, the reaction was terminated by placing the slides  in cold 
HMEM that contained 10 U heparin/ml and washed for  16-20 h. Cells were then fixed and 
stained for nonspecific esterase and counterstained with methyl green. For nonviable  cell assays, 
the cells were centrifuged onto the slides in a cytocentrifuge, fixed for 45 min in acetone, dried 
before pouring the agarose-plasma as described above, and then stained for nonspecific esterase. 
The presence of PCA was  clearly indicated by the formation of dark blue strands of fibrin 
about the single cells. This contrasted with the red cytoplasmic reaction for nonspecific esterase. 
Cytologic Staining.  Nonspecific esterase,  a highly reliable marker for monocytes and macro- 
phages, was identified as described by Li et al. (22). Cells were fixed for 30 see in 25% formalin 
in 45% acetone, buffered with 10 mM phosphate to 6.6 pH, and then were washed with water 
and dried. To each slide was added a mixture of 0.1  ml of 4 gm% hexazotized pararosanilin, 
and  0.2  ml  napthyl  butyrate  and  incubated for  45  min.  The  slides  were  washed,  dried, 
counterstained with 1% methyl green for 3 min and washed.  They were immediately examined 
for the cytoplasmic red reaction product of the esterase  reaction. Cell counts were based on 
examination of 100 cells. Hexazotized pararosanilin was prepared by mixing equal volumes of 
4%  pararosanilin hydrochloride  (J.  T.  Baker  Chemical  Co.,  Phillipsburg, N.  J.)  in  2  N 
hydrochloric acid with 4% sodium nitrate for 1 min immediately before use. a-Naptha butyrate 
(100 mg) was dissolved in 2 ml of ethylene glycol monomethyl ether and stored at 4°C. Methyl 
green stain was prepared by dissolving 1 gm methyl green in 100 ml of 0.1  N sodium-acetate 
buffer, pH 5.0. This was  titrated to pH 4.2-4.5 with hydrochloric acid, and extracted with 
chloroform until clear. 
Results 
Basal PCA.  Viable, as well as disrupted, cells were assayed to establish basal PCA 
level. The total PCA content of disrupted mononuclear cell preparations was quite 
consistent at 88 _+  18 milliunits in 10 experiments, whereas the PCA of the viable cells 
was  23  +  6  milliunits or  25%  of the  content  (Table I).  Total  PCA content of the 
lymphocyte subpopulation, separated on the basis of adherence and defined on the 
basis of lack ofesterase, positive neutral-red uptake, and morphology, was significantly 
less,  but  nonetheless positive at  36  +  12  milliunits. Expression  of PCA  by  viable 
lymphocytes was 9.5 +  1.I milliunits. Recovery of cells was 86 4" 3% and 78 +  2% for 
lymphocytes and macrophages, respectively. The macrophages, representing 12% of 
the average whole splenic mononuclear population based on neutral-red uptake and 
esterase staining, accounted for 67% of total PCA content and 68% of viable expression. 
Recovery of total and viable PCA, i.e., the sum of the lymphocyte and macrophage 
subpopulation, was  109% and 115%, respectively. 
Plaque Analysis.  Cellular distribution of PCA was analyzed directly using plaque 
assays of both viable and fixed cells. In this assay, cells were overlaid by agarose that 
contained dilute plasma and calcium for a  10-min assay period to permit formation 
of local  fibrin. After termination and washing, the  cells were  fixed  (if viable)  and GARY A.  LEVY  AND THOMAS S.  EDGINGTON 
TABLE  I 
Basal Levels of PCA of Splenic Mononuclear Cells 
1235 
PCA per 10  7 cells 
Cell population  Viable expression  Total content 
Time  Milliunits  Time  Milliunits 
SeC  SeC 
Whole mononuclear cells  130 + 6.5  23 ±  6  90 +  5  88 ±  18 
Lymphoeytes  165 4- 25  9.5 4- 1.1  115 ±  10  36 ±  12 
Macrophages  76 4- 6  150 4- 35  55 4- 7  535 ±  75 
HMEM  225 ±  30  0.4 ±  . 1  225 ±  30  0.4 4- . l 
Splenic mononuclear cells from A/St and BALB/c mice were cultured in HMEM. Lymphocytes were 1% 
nonspecific-esterase  positive, and macrophages after nonadherent cell removal were 98% esterase  positive. 
FIc.  1.  Plaque assay  for demonstration of PCA in individual cells from whole,  splenic  mononu- 
clear-cell  preparations either stimulated with LPS or unstimulated. (A) Fixed, esterase-positive  cell 
(macrophage)  from cells not exposed  to LPS and negative for PCA (no fibrin strands).  (B) Fixed, 
esterase-positive  cell (macrophage)  from cells stimulated with LPS and positive  for PCA (presence 
of fibrin  strands).  (C)  Fixed esterase-positive  cell that  is  positive for  PCA  (fibrin  strands)  and 
esterase-negative  cell (lymphocyte)  (arrow)  that  is negative for  PCA from cells exposed  to  LPS. 
Note: The esterase reaction cannot be differentiated in the black-and-white photographs. 
stained  for esterase.  Morphologic identity of the ceils by reference to the cytoplasmic 
red esterase  reaction,  and  the identification  of PCA-positive cells by reference to the 
presence of fine blue strands  of fibrin that  surrounded  the cells was readily apparent 
(Fig.  1).  Only ~  1% of cells were PCA positive in the viable state, and of these cells, all 
were macrophages;  i.e., esterase positive. Total PCA content was assessed in fixed-cell 
preparations  and  indicated  that  only -3%  of cells were positive, of which,  80%  were 
macrophages  (Table  II). The  rare  esterase-negative  but  PCA-p0sitive cells appeared 
cytologically consistent with lymphocytes, though this will require further verification. 
This is in agreement with assays of cell suspensions which showed that the lymphocyte 
population  possessed  low levels of PCA  though  sufficient  to account  for 32%  of total 
or 33% of viable expression of the basal  PCA of the whole mononuclear  cell mixture. 
Stimulation  of PCA  by  Bacterial  LPS.  Whole  splenic  mononuclear  cells were  incu- 
bated in complete medium  with E.  coli 0111 :B4 LPS for 6  h. When  assayed  for direct 
viable  PCA  as  well as  total  PCA  content  of disrupted  cells,  there  was  a  significant 1236  MACROPHAGE  PROCOAGULANT ACTIVITY 
TABLE  II 
Plaque Assay for PCA of Cells 
Cells  LPS stimula-  Esterase  positive  Esterase  nega- 
tive and PCA 
tion  and PCA positive  positive 
% 
Viable  0  1  0 
+  80  5 
Fixed  0  2.4  0.6 
+  100  8 
1,000- 





1'2  o.1 
Incubation (h)  LPS  (/~glml) 
1~o 
Fio. 2.  Induction by LPS of PCA in murine spleen cells. (A) 5 ×  106 murine splenic leukocytes 
were incubated with 10 p.g LPS (from E. coli 011 l:B4) for time intervals of 30 min-20 h, and total 
PCA content was determined. (B) 5 X 106 murine splenic leukocytes were incubated for 6 h with 
increasing concentrations of butanol-extracted LPS (from E. coli 0111  :B4) from 0.1 to 100 #g, and 
the total content of PCA was determined. 
increase as compared to basal levels. The time-course for optimal amplification of the 
PCA content of whole mononuclear cells was examined (Fig. 2 A). When  10/zg/ml 
LPS and 5 ×  106 cells/ml was used, an increase from basal activity (80 milliunits) was 
not observed for  2  h,  and then increased to  a  maximum of 800  milliunits by 6  h. 
Activity declined  only  slightly  during the  following  18  h.  A  representative  dose- 
response curve is shown in Fig. 2 B. Incubation of splenic mononuclear  cells with serial 
concentrations of LPS for 6 h  at 37°C demonstrated maximum induction of PCA at 
a  concentration of 10 #g LPS/ml, declining sharply at higher concentrations. Subse- 
quent studies uniformly utilized  10/tg LPS/ml and 6  h  of incubation. Subsequent 
pulses of LPS at 6,  12, or 24 h  after the initial stimulation did not further increase 
PCA. 
Quantitative analysis of PCA stimulation by LPS in a  series of seven experiments 
is shown in Table III. At 6  h, there was a  fourfold increase of expression by whole 
viable mononuclear cells in contrast to a  10.4-fold increase in total cellular content of 
PCA. Whereas the viable expression of PCA was ~25% of the total cellular content, 
in the basal state, after LPS stimulation, the viable PCA was increased fourfold, but 
represented only 10% of the total content. No significant change was observed at  24 
h  or by subsequent pulses of LPS at 6,  12, or 24 h. 
Plaque  assay  of  PCA  of  LPS-stimulated  viable  mononuclear cells  (Table  II), GARY A.  LEVY AND THOMAS S.  EDGINGTON 
TABLE III 




PCA per  10  7 ceils 
Viable expression  Total content 
Stimu-  Stimu- 
Time  Milliunits lated/  Time  Milliunits  lated/ 
basal  basal 
$CC  $~C 
Whole  mononuclear  90 ±  10  92 -t- 18  4.0  50 ± 5  910 +  110  10.4 
cells 
Lymphocytes:~  165 ± 25  9.5 ±  1.1  1.0  115 ±  l0  36 +  12  1.0 
Macrophages§  75 ± 5  155 ± 40  1.0  55 ± 3  540 ± 75  1.0 
* 6-h incubation with E. coli 0111  :B4 LPS at 10 #g/ml. 
:]: < 1% nonspecific-esterase positive. 
§ >98% nonspecific-esterase positive. 
indicated that 80% of the esterase-positive cells (12-15% of cells) were positive and 5% 
of the  esterase-negative  cells  were  positive  for  PCA  (Fig.  1).  The  latter  appeared 
cytologically to be  lymphocytes.  PCA plaque  assay of fixed  LPS-stimulated  mono- 
nuclear cells demonstrated that  100% of the esterase-positive cells were PCA positive 
and  8%  of  the  esterase-negative  mononuclear  cells  were  also  positive  for  PCA, 
suggesting PCA production by a  lymphocyte subpopulation. 
LPS Stimulation of Cell Populations.  In  contrast  to  the  LPS  stimulation  of whole 
mononuclear cells,  when  isolated  macrophages  (>98%  esterase  positive)  were  incu- 
bated with LPS and assayed 6 h  later for PCA, there was no increase in PCA (Table 
III). Similarly, when lymphocytes were isolated (< 1% esterase positive) and incubated 
with LPS, there was no increase in PCA. 
In contrast to the lack of response of isolated lymphocytes or macrophages to LPS, 
when  whole  splenic  mononuclear  cells  were  incubated  for 6  h  with  LPS  and  the 
macrophages  and  lymphocytes isolated  by adherence  and  assayed  for total  PCA,  a 
significant response of macrophages was observed. The PCA of the splenic mononu- 
clear cells increased  11.1-fold from 88 milliunits  (basal)  to 910 milliunits  (Table IV). 
When the two subpopulations were separated  by adherence  and assayed separately, 
we could account  for 95.8%  of PCA. The  PCA of macrophages recovered  from the 
stimulated  cells  increased  12.1-fold  from  570  milliunits  to  6,920  milliunits  and 
accounted  for  95.2%  of  the  PCA  of  the  whole,  splenic  mononuclear  cells.  The 
lymphocytes isolated from the LPS-stimulated mononuclear cells showed only a slight 
increase of PCA above basal, even though these cells had been stimulated by LPS in 
the presence of macrophages, and the lymphocyte subpopulation  contained 4.8% of 
total PCA. The validity of separating LPS-stimulated lymphocytes and macrophages 
by adherence was supported by cytology and esterase reactions. 
Lymphocyte Requirement for  Generation of Macrophage PCA.  To  further  define  the 
requirements  for amplification of PCA content of macrophages, splenic mononuclear 
cells  were  separated  into  macrophages  and  lymphocytes.  The  lymphocytes  were 
incubated for 6 h with LPS, then macrophages were incubated for 6 h with either the 
LPS-stimulated lymphocytes in fresh medium or the medium from the same lympho- 
cytes. When  1 ×  106 macrophages that had been incubated with the LPS-stimulated 1238  MACROPHAGE  PROCOAGULANT  ACTIVITY 
TABLE  IV 
PCA of Cell Subpopulations Derived  from LPS-stimulated Whole  Splenic Mononuclear Cells 
Total PCA per 10  7 cells 
Cell  subpopulation  Basal  LPS-stimulated 
Time  Milliunits  Time  Milliunits 
sec  5gC 
Whole mononuclear cells  90 ±  10  88 -  18  50 ±  5  910 ±  110 
Lymphocytes*  115 ±  10  36 ±  12  110 ±  12  48 ±  14 
Macrophages:~  50 ±  3  570  ±  154  26 ±  2  6920 ±  750 
* Lymphoeytes < 1% esterase positive. Stimulated with LPS in presence of macrophages and subsequently 
isolated and assayed for PCA. 
~: Macrophages >98% esterase positive. Stimulated with LPS in presence of lymphocytes and subsequently 
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Fzo.  3.  Macrophage PCA recovered from LPS-stimulated murine splenic mononuclear cells. [LPS- 
SMC]---~ M~ (A): splenic  mononuclear cells were incubated with  I0/~g LPS for 6 h, and then the 
macrophages  were isolated and assayed for PCA content at serial  cell concentrations.  [LPS-L]  + 
M~  (0):  lymphocytes were  incubated with  LPS  for  6  h  before  their  addition  to  macrophages 
followed by incubation for 6 h, after which, macrophages  were isolated and the total content of 
PCA was measured. Mq~ (ml): macrophages that were assayed for total PCA content. [LPS-L-S/N] 
+  Mq~ (O)  lymphocytes were incubated with LPS for 6 h after which, the supernate was added  to 
macrophages for a 6-h incubation and the macrophages were assayed for total PCA content. Normal 
plasma substrate was used in these assays and demonstrated the typically nonproportionality and 
nonlinearity  at  <105  cells.  This demonstrates the  collaborative  requirement  in  generating  PCA 
activity and the typical characteristics both at the high and low range. GARY  A.  LEVY  AND  THOMAS  S.  EDGINGTON 
TABLE  V 
Cooperative Induction of PCA in Macrophages by LPS-stimulated  Lymphocytes 
1239 
Added to  1 x  10  7 macrophages 
Total macrophage PCA per  10  7 cells 
Basal  Stimulated 
LPS-stimulated lymphocytes (9 X  10  7  770:1:155 
cells) 
LPS-stimulated  lymphocyte  medium  770 ±  155 
(from 9 x  107 cells, above*) 
milliunits 
6,920 ±  770 
755 ±  155 
* Supernatant medium clarified at  100,000 g for 1 h. 
TABLE VI 
Cell Specificity for Induction of LPS-stimulated  Macrophage PCA 
Cells added to  1 X  10  6 macro- 
phages 
LPS-stimulated* PCA per 107 macro- 
phages 
Time  Milliunits 
$cc 
None  69 +  3  2,300 ±  400 
Lymphocyte (9 ×  106)  49 +  2  7,700 ±  750 
Neutrophil (1.3 ×  106)  69 ±  3  2,280 ±  380 
RBC (1 ×  106  )  71 ±  2  2,150 ±  300 
* LPS from E. coli 011 hB4:10 #g/ml. 
9,ooo 
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FIG.  4.  Lymphocyte requirement  for  amplification  of macrophage  procoagulant  activity.  (A): 
LPS-stimulated macrophages (1 ×  10  v) were incubated with increasing numbers of lymphocytes to 
give the ratio of lymphocytes: macrophages given on the abscissa. The cells were incubated with  10 
#g LPS for 6 h, and macrophages were isolated and assayed for total PCA content. (0) : macrophages 
(1 ×  107) were incubated with lymphocytes in increasing numbers to give ratios of lymphocytes to 
macrophage as above. The cells were incubated for 6  h  without  LPS and the macrophages were 
assayed for total PCA. 1240  MACROPHAGE  PROCOAGULANT  ACTIVITY 
lymphocytes were assayed, there was  a  ninefold increase in  PCA within  the linear 
range of the assay when conducted with normal plasma (Fig. 3). The nonproportion- 
ality of the PCA at  low cell numbers is similar to that  originally described for low 
concentrations of thromboplastin (20) and paralleled that for LPS-stimulated, whole 
mononuclear cells from which the macrophages were recovered and assayed. When 
assayed in Factor VIII-deficient plasma, a  typical linear yield of PCA was observed 
in accord with other studies (21). No increase was observed for macrophages incubated 
with the medium  from the LPS-stimulated lymphocytes (Table V). The molecular 
aspects will be reported subsequently. 
From these experiments, we suggest that the macrophage is the cell responsible for 
the increased content of PCA;  however, amplification of PCA content requires the 
presence of intact lymphocytes that had been exposed to LPS. Evidence for unilateral 
collaboration follows from similar experiments in which LPS-stimulated macrophages 
were added to lymphocytes. No amplification of PCA was observed, indicating that 
the LPS-lymphocyte can  induce macrophage  PCA,  but  that  the  LPS macrophage 
does not stimulate lymphocytes, macrophages, or a reciprocal circuit of macrophage- 
lymphocyte to induce macrophages to increase PCA content. 
To assess cellular specificity of the requirement for lymphocyte collaboration, the 
capacity of neutrophils  and  erythrocytes (RBC)  to collaborate in  the  induction  of 
macrophage PCA was examined (Table VI). The macrophages stimulated with LPS 
in the presence of lymphocytes showed a 3.3-fold increase in PCA, whereas no increase 
was observed for macrophages incubated with RBC or neutrophils in the presence of 
LPS. 
The optimal lymphocyte:macrophage ratio for PCA  induction was examined by 
adding either no lymphocytes, or serial concentrations of lymphocytes from  1 ×  10 7 
through 1 X  10  s, to 1 ×  10 7 macrophages to give lymphocyte ratios of0:1 to I0:1, and 
then stimulating with LPS (Fig. 4). Total cellular PCA, remained at basal  levels for 
lymphocyte:macrophage ratios of 0-2:1 but increased sharply to 8,864 milliunits at a 
4:1 ratio and could not be further augmented. 
Discussion 
Our study provides direct evidence for cellular collaboration in the induction of the 
coagulation  pathways  by  the  lymphoid  system.  In  our  experiments,  the  model 
stimulant  LPS was used. A  variety of in vitro stimuli including allogeneic reactions 
(10), cell-bound antibody,  z immune complexes  (9)  and  lectins  (3,  12,  23,  24)  have 
been reported to generate PCA  of thromboplastin-like character in  lymphoid cells 
(10, 13, 16, 23); and, indeed, certain phenotypic features ofimmunologically-mediated 
tissue lesions have suggested that local activation of the coagulation system occurs in 
vivo (1, 2, 5-7). There is, to date, limited characterization of the phenomenon, and 
neither the responsible cells nor the cellular requirements for induction of this type of 
response have been clearly delineated. 
Our studies of LPS-induced PCA in murine lymphoid cells provide direct evidence 
that splenic mononuclear cells possess low basal levels of PCA, which appears to be 
2 Rothberger, H., J. Dunne, and T. S. Zimmerman. Increased production of tissue thromboplastin-like 
procoagulant activity stimulated by red cells sensitized with human anti-blood alloantibodies. Manuscript 
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tissue  factor  in  respect  to  its  dependence  on  Factor  VII.  It  is  observed  in  both 
lymphocytes and macrophages by reference to separated cell populations where -67% 
was macrophage associated. The development ofa procoagulant plaque assay coupled 
with vital neutral-red uptake and a  reaction for nonspecific esterase of macrophages 
has permitted simultaneous use of cytologic, histochemical, and  functional  markers 
on single cells. It has thus been possible to demonstrate that PCA is expressed by only 
-1%  of viable splenic  mononuclear cells,  and  all  were  macrophages.  About  3%  of 
fixed cells contained PCA and 80% of these were macrophages, and very few (~0.7%) 
of cells that were esterase negative and appeared cytologically similar to lymphocytes 
contained PCA. Whether these latter cells are lymphocytes remains to be clarified. 
The stimulation of splenic mononuclear cells with LPS led to a significant ampli- 
fication of total  PCA  in  agreement with  Garg and  Niemetz  (13)  and  Lerner et  al. 
(23).  It has been suggested that as little as  1 ng of LPS might elicit this activity (25), 
and  that  it may be observed within  1 h  (26)  and  reach a  maximum concentration 
within 6 h  (16,  23). We have observed some variability between preparations of LPS 
in dose and temporal sequence, but in general, maximal induction  is in the range of 
concentration of LPS necessary for induction of mitogenic activity, and 6 h  has been 
required  for maximum effect. We, like Rapaport et al.  (27), observed no significant 
increase of PCA with exposures to LPS of<2 h; however, it should be noted that the 
relatively  brief period  of LPS  exposure  required  for  PCA  generation  precludes  a 
proliferative requirement and suggests a direct inductive event. 
At 6 h, most of the newly-generated PCA remains intracellular (Table III), and we 
have observed this to also be true at 24 h. There is a  10-fold increase over basal levels, 
whereas the activity expressed by viable cells increased only 4-fold over basal. The 
observation that  the  increased  PCA  is  for the most part  not  made available in  the 
viable state is in keeping with the observations of Niemetz et al.  (26), who localized 
tissue  factor  (thromboplastin)  to a  light-microsomal  fraction  consistent  with  endo- 
plasmic reticulum. Some investigators have suggested that a second pulse of endotoxin 
enhances generation of PCA;  however, we have observed that at an optimal dose of 
LPS, there is no further increases with a second pulse of LPS at 6,  12, or 24 h after the 
initial stimulation. 
Plaque assays of LPS-stimulated cells demonstrated a significant increase of PCA- 
positive viable cells. In contrast to the  1% PCA-positive cells in basal cultures, ~ 14- 
15% of cells were positive and -80% of the macrophages expressed PCA within 6 h 
after LPS stimulation. This study supports the analyses of the fractionated cells after 
LPS stimulation  where 95% of the  PCA was recovered with macrophages of 99.5% 
purity.  In addition,  it was observed that  8% of esterase-negative cells, cytologically 
compatible with lymphocytes, also were positive after LPS stimulation, though there 
was little increase in quantity of PCA in the isolated lymphocytes. Presumably, the 
PCA content per cell must be much lower than for macrophages. Whether these cells 
are lymphocytes remains to be established by a  more detailed study. 
We observed that neither isolated lymphocytes nor isolated macrophages could be 
independently stimulated by LPS to generate this activity. When macrophages were 
supplemented  with  lymphocytes to  a  minimum  ratio  of 3:1  (lymphocytes:macro- 
phages) (Fig. 4) and then stimulated with LPS, there was PCA generation. Similarly, 
if  the  lymphocytes  had  previously  been  stimulated  by  LPS  and  were  added  to 
macrophages, additional PCA was generated by the macrophages. This is in contrast 1242  MACROPHAGE  PROCOAGULANT  ACTIVITY 
to Edwards and Rickles (28), who, using human cells, have suggested in a preliminary 
report that lymphocytes serve to augment the amplification of PCA but that isolated 
macrophages  could  be  stimulated  to  increase  PCA.  Whether  their  macrophage 
preparations had sufficient lymphocyte contamination to permit partial induction is 
not known. 
In our study, it appears that macrophages can be stimulated to increase PCA only 
when stimulated in the presence of LPS-triggered lymphocytes. All cells, including T 
and  B  lymphocytes, RBC, and neutrophils have cell-surface receptors for LPS (29, 
31). However, neither neutrophils nor RBC could induce PCA in macrophages; only 
lymphocytes participated in this collaboration. Thus simple presentation of  cell-bound 
LPS is insufficient. Furthermore, no increase in PCA was observed when lymphocytes 
were incubated with isolated macrophages that  had been previously stimulated  by 
LPS and then washed to remove free LPS. This is strong evidence that lymphocytes 
must be exposed to the LPS as the primary event and then either present the LPS to 
the macrophage  (or some LPS-stimulated mediator)  to induce production of PCA. 
We were unable to demonstrate that a soluble mediator was produced by lymphocytes 
and  released  into  the  medium  from  LPS-stimulated  lymphocytes, suggesting  that 
lymphocyte collaboration may be mediated via contact. Recent experiments ((3. A. 
Levy and T.  S.  Edgington.  Unpublished  results.)  have shown  that  there is  genetic 
restriction in the collaborative interaction between lymphocytes and macrophages in 
this response. A minimum 3:1 ratio of lymphocytes:macrophages with a sharp rise to 
maximum at 4:1 is consistent with a stoichiometric interaction, even physical associ- 
ation, with a minor subset of lymphocytes. 
It is well recognized (32,  33)  that  macrophages are required for the proliferative 
response of murine spleen cells.  However, more recently, Tzehoval et al.  (34)  have 
shown that T  lymphocytes are capable of regulating, or are required for independent 
induction of the phagocytic properties of macrophages. Thus, although there has been 
considerable  attention  to  the  regulation  of a  variety of lymphocyte functions  by 
macrophages, the capacity oflymphocytes to regulate macrophage function, including 
the generation or expression ofmonokines, is exemplified by the lymphocyte-controlled 
generation of procoagulant molecules. The significance of this lymphoid pathway has 
only been  suggested  by observations of fibrin  deposition  in  a  number of types of 
immunologic  lesions;  however,  the  possibility  of a  direct  participant  function  or 
requisite  role  can  not  be  ignored.  Fibrinolysis  releases  a  peptide  that  suppresses 
lymphocyte function from the a-chain of fibrin (35). Whether this peptide is a  toxic 
cofactor in  target  cytolysis or,  on  the other hand,  suppresses  the  cellular immune 
attack, it will be evoked only secondary to local induction of  coagulation, a mechanism 
which can now more clearly be envisioned as a systematic byproduct of immunologic 
reactions. 
Summary 
Murine  splenic  lymphoid  cells  have  been  shown  to  possess  basal  procoagulant 
activity. This activity was localized to most macrophages by assay of cell populations, 
as well as by a  direct plaque assay that permitted identification of expressed proco- 
agulant activity of individual viable cells as well as content. Both content and viable 
expression of procoagulant activity was markedly increased by exposure to bacterial 
lipopolysaccharide,  reaching  a  maximum  after 6  h.  The  quantitative  increase  in 
procoagulant activity content and viable expression was limited to the macrophage GARY  A.  LEVY AND THOMAS S.  EDGINGTON  1243 
population.  Separated  populations  of lymphocytes  or  macrophages  could  not  be 
stimulated  by  lipopolysaccharide  to  increase  procoagulant  activity,  whereas  the 
addition of lymphocytes to macrophages at a  3-4:1 ratio maximally reconstituted the 
amplification  of procoagulant  activity.  Further  evidence  of cellular  collaboration 
followed from observations that only lymphocytes that had been exposed to lipopoly- 
saccharide  were  capable  of triggering  the  increase  in  macrophage  procoagulant 
activity. This appears to represent a new form of lymphocyte-macrophage cooperation 
in an effector pathway that may participate  in some forms of immunologic responses 
and contribute to the phenotypic features of certain immunologic tissue lesions. 
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